Nextgen Healthcare, INC. Stock: price and management transactions · United States · SEC (Form 4)Follow the Nextgen Healthcare, INC. stock price and the full management transaction log of the company, a listed issuer based in United States. Shares are quoted on the US market, under the authority of SEC (Form 4). Operating in the Healthcare & Pharma sector, Nextgen Healthcare, INC. has logged 153 public disclosures. The latest transaction was disclosed on 13 November 2023 (Disposition). Among the most active insiders: Metcalfe David A. Every trade is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 13 November 2023
All Executives153 Thresholds0 Prospectus0 Other0
Declarations 153 total
● EVP, Commercial Growth · Executives · 9 Nov 2023
57,931 shares Common Stock SEC:0000950170-23-062960:0
● Director · Executives · 9 Nov 2023
136,393 shares Common Stock SEC:0000950170-23-062987:0
● Director · Executives · 9 Nov 2023
70,104 shares Common Stock SEC:0000950170-23-062948:0
● Chief Accounting Officer · Executives · 9 Nov 2023
44,555 shares Common Stock SEC:0000950170-23-063049:0
● Chief Financial Officer · Executives · 9 Nov 2023
515,786 shares Common Stock SEC:0000950170-23-063007:0
● Director · Executives · 9 Nov 2023
82,889 shares Common Stock SEC:0000950170-23-063012:0
● Director · Executives · 9 Nov 2023
67,269 shares Common Stock SEC:0000950170-23-063056:0
● See Remarks · Executives · 9 Nov 2023
361,586 shares Common Stock SEC:0000950170-23-062959:0
● Director · Executives · 9 Nov 2023
32,877 shares Common Stock SEC:0000950170-23-063011:0
● Director · Executives · 9 Nov 2023
31,028 shares Common Stock SEC:0000950170-23-063033:0
● Director · Executives · 9 Nov 2023
31,028 shares Common Stock SEC:0000950170-23-062994:0
● President and CEO · Executives · 9 Nov 2023
605,540 shares Common Stock SEC:0000950170-23-063054:0
● Director · Executives · 9 Nov 2023
100,043 shares Common Stock SEC:0000950170-23-062928:0
● EVP, General Counsel/Secretary · Executives · 9 Nov 2023
95,568 shares Common Stock SEC:0000950170-23-062996:0
● President and CEO · Executives · 7 Nov 2023
6,500 shares 0Common Stock SEC:0000950170-23-063039:0
● Chief Financial Officer · Executives · 8 Nov 2023
6,296 shares 0Common Stock SEC:0000950170-23-063006:0
● Director · Executives · 1 Nov 2023
9,418 shares 0Common Stock SEC:0000950170-23-062956:0
● Chief Accounting Officer · Executives · 30 Oct 2023
1,554 shares @ US$23.89 13.9% of flow Common Stock SEC:0001209191-23-054037:0
● EVP, Commercial Growth · Executives · 30 Oct 2023
3,842 shares @ US$23.89 10.8% of flow Common Stock SEC:0001209191-23-054042:0
● Chief Growth & Strategy Office · Executives · 30 Oct 2023
9,505 shares @ US$23.89 12.4% of flow Common Stock SEC:0001209191-23-054041:0
● EVP, General Counsel/Secretary · Executives · 30 Oct 2023
3,802 shares @ US$23.89 11.8% of flow Common Stock SEC:0001209191-23-054039:0
● Chief Financial Officer · Executives · 30 Oct 2023
8,848 shares @ US$23.89 20.4% of flow Common Stock SEC:0001209191-23-054038:0
● President and CEO · Executives · 30 Oct 2023
18,931 shares @ US$23.89 70.4% of flow Common Stock SEC:0001209191-23-054040:0
● EVP, Commercial Growth · Executives · 27 Oct 2023
2,751 shares @ US$23.86 7.7% of flow Common Stock SEC:0001209191-23-053882:0
● Chief Financial Officer · Executives · 27 Oct 2023
5,907 shares @ US$23.86 13.6% of flow Common Stock SEC:0001209191-23-053878:0
25 of 153 declarations
Load more (128 remaining) 关于 Nextgen Healthcare, INC. NextGen Healthcare, Inc. (NXGN) 是一家美国医疗技术公司,历史上与纳斯达克市场相关联。该公司在所有权变更后现已私有化,但在美国门诊医疗保健软件领域仍然是一个知名品牌。NextGen 成立于 1974 年,当时名为 Quality Systems, Inc. (QSI),几十年来一直致力于构建一个旨在简化诊所运营并改善行政团队、临床医生和患者之间协调的软件平台。([nextgen.com](https://www.nextgen.com/company/newsroom/press-release/NextGen-Healthcare-Launches-Bold-Platform-Future-with-New-Brand-Identity?utm_source=openai))
公司的核心业务围绕集成电子健康记录 (EHR) 软件、诊所管理、收入周期管理、患者沟通工具、分析和工作流程自动化。NextGen 主要专注于门诊护理领域,服务于各种医疗团体、专科诊所和社区卫生中心。该公司在其企业网站上表示,它支持全国数千个组织,拥有超过 75,000 个地点,并覆盖许多临床专科。([nextgen.com](https://www.nextgen.com/company/about-us?utm_source=openai))
从竞争角度来看,NextGen 将自己定位为一家专业的医疗保健 IT 提供商,高度重视门诊诊所的端到端工作流程集成、运营效率和财务绩效。这种利基重点有助于将其与更广泛的通用软件供应商区分开来,特别是对于需要合规支持、生产力工具和更好收入可见性的客户。该公司还强调其在某些专业领域(包括行为健康)的专业知识,这可以增强其在选定垂直领域中的地位。([nextgen.com](https://www.nextgen.com/company/about-us?utm_source=openai))
其主要产品和服务包括 NextGen Enterprise、NextGen Office、患者参与解决方案、分析工具以及更新的 AI 赋能产品。在 2024 年和 2025 年,NextGen 推出并扩展了 AI 驱动的产品,例如 NextGen Ambient Assist 和 NextGen Navigator,两者都旨在减少行政负担、加快患者互动并提高员工生产力。在 2026 年 4 月,该公司还推出了焕然一新的品牌形象和更明确的以 AI 和智能自动化为中心的平台愿景。([nextgen.com](https://www.nextgen.com/company/newsroom/press-release/nextgen-healthcare-expands-capabilities-of-nextgen-ambient-assist?utm_source=openai))
从地理上看,NextGen Healthcare 被描述为一家在美国以远程优先的组织,其业务遍及全国各地的门诊诊所,而不是传统的单一办公室模式。最近的公司通讯提到了旧金山、芝加哥和纳什维尔等地,这表明其采用分布式运营模式。对于法国、比利时和瑞士的投资者而言,NXGN 符合不断增长的医疗保健软件主题:结构性需求受到临床工作流程数字化的支持,但该公司也面临激烈的竞争,并受到客户资本支出周期的影响。最近的里程碑包括 2025 年的所有权变更、领导层过渡活动以及 2026 年的品牌重塑,所有这些都强化了公司向 AI 赋能平台服务的战略转变。([nextgen.com](https://www.nextgen.com/company/newsroom/press-release/nextgen-healthcare-welcomes-madison-dearborn-partners?utm_source=openai))